Quarterly report pursuant to Section 13 or 15(d)

Note 19 - Concentrations

v3.24.3
Note 19 - Concentrations
9 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Concentration Risk Disclosure [Text Block]

Note 19. Concentrations

 

e-Commerce Operations concentrations:

 

Customers:

 

Sales to customers through Amazon accounted for 35.8% and 49.1% of the Company’s revenues during the nine months ended September 30, 2024 and 2023, respectively. No other customer accounted for 10% or more of the Company’s revenues for either period.

 

Suppliers:

 

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s purchases for the three and nine months ended September 30, 2024 and 2023 (in thousands):

 

   

For the Three Months Ended September 30,

 
   

2024

   

2023

 
   

Amount

   

% of Total Purchases

   

Amount

   

% of Total Purchases

 

Iridium Satellite

  $ 378       14.5 %   $       %

Garmin

  $ 373       14.3 %   $ 444       23.2 %

Globalstar

  $ 280       10.8 %   $ 186       9.7 %

Maklink

  $ 264       10.1 %   $       %

 

   

For the Nine Months Ended September 30,

 
   

2024

   

2023

 
   

Amount

   

% of Total Purchases

   

Amount

   

% of Total Purchases

 

Iridium Satellite

  $ 1,314       18.1 %   $ 798       12.0 %

Garmin

  $ 867       12.0 %   $ 1,494       22.5 %

Globalstar

  $ 754       10.4 %   $ 706       10.6 %

     

Geographic:

 

The following table sets forth revenue as to each geographic location (in thousands):

 

   

For the Three Months Ended September 30,

 
   

2024

   

2023

 
   

Amount

   

% of Total

   

Amount

   

% of Total

 

Europe

  $ 2,018       52.6 %   $ 1,715       58.5 %

North America

    1,349       35.2 %     737       25.1 %

South America

    10       0.3 %     432       14.7 %

Asia and Pacific

    429       11.2 %     24       0.8 %

Africa

    28       0.7 %     23       0.8 %
    $ 3,834       100 %   $ 2,931       100 %

 

   

For the Nine Months Ended September 30,

 
   

2024

   

2023

 
   

Amount

   

% of Total

   

Amount

   

% of Total

 

Europe

  $ 5,434       53.2 %   $ 5,382       61.4 %

North America

    2,894       28.3 %     2,194       25.0 %

South America

    41       0.4 %     1,026       11.7 %

Asia and Pacific

    1,275       12.5 %     121       1.4 %

Africa

    566       5.5 %     41       0.5 %
    $ 10,210       100 %   $ 8,764       100 %

 

Healthcare operations concentrations:

 

Suppliers:

 

Progressive Care had significant concentrations with one vendor. The purchases from this significant vendor were 98.0% of total vendor purchases for the nine months ended September 30, 2024.

 

Customers:

 

Progressive Care trade receivables are primarily from prescription medications billed to various insurance providers. Ultimately, the insured is responsible for payment should the insurance company not reimburse Progressive Care.

 

Progressive Care derives a significant portion of sales from prescription drug sales reimbursed through prescription drug plans administered by PBM companies. Prescription reimbursements from our three most significant PBMs were as follows:

 

   

Nine Months Ended September 30, 2024

 

A

    29 %

B

    25 %

C

    11 %